The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Oncologist Thomas C. Weiner misdiagnosed Anthony Olson with MDS in 2011. Olson is one of many patients who may have received unnecessary and harmful treatments after being misdiagnosed by Weiner.

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

Clear toxicity data reporting and interpretation are necessary for clinicians and patients to draw clinically meaningful conclusions from clinical trials,” according to researchers.

The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...

Scheduling radiotherapy in the morning may be beneficial for patients with nasopharyngeal carcinoma, but additional study is needed to confirm this finding, according to researchers.

Data suggest that states with strict abortion bans are losing residents, particularly younger people, which could have long-term economic implications.

Physicians have a duty of care, which includes calling for payer reform and ending practices that are killing patients, ...

Obesity at childhood cancer diagnosis was independently associated with inferior survival, and this was likely driven by trends detected in children with acute lymphoblastic leukemia or central ...

The combination of talquetamab and teclistamab “warrants further investigation in patients with relapsed or refractory multiple myeloma,” according to researchers.